Nicolas U Gerber
Overview
Explore the profile of Nicolas U Gerber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Place A, Karol S, Forlenza C, Cooper T, Fraser C, Cario G, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31630.
PMID: 40062648
Background: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and although many patients respond to induction therapy, those who relapse or have refractory disease face a poor prognosis....
2.
Fernandes Dias S, Oertel M, Stucklin A, Gerber N, Colombo E, van Doormaal T, et al.
Front Surg
. 2025 Feb;
11:1462074.
PMID: 39897706
The use of magnetic resonance-guided laser interstitial thermal therapy (LITT) for the treatment of brain tumors and epileptic lesions has increased in the field of pediatric neurosurgery. However, very little...
3.
Friker L, Perwein T, Waha A, Dorner E, Klein R, Blattner-Johnson M, et al.
Acta Neuropathol
. 2025 Feb;
149(1):11.
PMID: 39894875
Pediatric high-grade glioma (pedHGG) can occur as first manifestation of cancer predisposition syndromes resulting from pathogenic germline variants in the DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1, and PMS2....
4.
Lamoureux A, Fisher M, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm C, et al.
Clin Cancer Res
. 2024 Dec;
31(3):561-572.
PMID: 39625867
Purpose: Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients. Experimental Design:...
5.
Gaspar N, Hung G, Strauss S, Campbell-Hewson Q, Dela Cruz F, Glade Bender J, et al.
JAMA Oncol
. 2024 Oct;
10(12):1645-1653.
PMID: 39418029
Importance: The combination of ifosfamide and etoposide (IE) is commonly used to treat relapsed or refractory osteosarcoma; however, second-line treatment recommendations vary across guidelines. Objective: To evaluate whether the addition...
6.
Palenzuela G, Schiffler C, Frappaz D, Peyrl A, Gerber N, Kortmann R, et al.
Front Oncol
. 2024 Jul;
14:1421418.
PMID: 39077474
Background: SIOP-CNS-GCT-II European trial was opened for the treatment of patients of any age with central nervous system germ cell tumour (CNS-GCT). Four courses of pre-irradiation chemotherapy were delivered. The...
7.
Mynarek M, Rossius A, Guiard A, Ottensmeier H, von Hoff K, Obrecht-Sturm D, et al.
Neuro Oncol
. 2024 Jun;
26(11):2113-2124.
PMID: 38835160
Background: Neurocognition can be severely affected in pediatric brain tumor survivors. We analyzed the association of cognitive functioning with radiotherapy dose, postoperative cerebellar mutism syndrome (pCMS), hydrocephalus, intraventricular methotrexate (MTX)...
8.
Nussbaumer G, Benesch M, Grabovska Y, Mackay A, Castel D, Grill J, et al.
Neuro Oncol
. 2024 May;
26(9):1723-1737.
PMID: 38717379
Background: The term gliomatosis cerebri (GC), a radiology-defined highly infiltrating diffuse glioma, has been abandoned since molecular GC-associated features could not be established. Methods: We conducted a multinational retrospective study...
9.
Obrecht-Sturm D, Schomig L, Mynarek M, Bison B, Schwarz R, Pietsch T, et al.
Neuro Oncol
. 2024 Apr;
26(9):1712-1722.
PMID: 38578306
Background: This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma. Methods: Data on 84 pediatric patients with medulloblastoma and persistent residual lesions...
10.
Kilburn L, Khuong-Quang D, Hansford J, Landi D, van der Lugt J, Leary S, et al.
Nat Med
. 2024 Mar;
30(5):1500.
PMID: 38467878
No abstract available.